Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Lung Cancer

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 55 articles: HTML format Text format

Single Articles

January 2012
1. MAUCERI HJ , Sutton HG, Darga TE, Kocherginsky M, et al
   Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer.
   Oncol Rep. 2012 Jan 27. doi: 10.3892/or.2012.1666.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. QU Y , Yang Y, Ma D, Xiao W, et al
   Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer.
   Oncol Rep. 2012 Jan 11. doi: 10.3892/or.2012.1627.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. HE SS , Shi HS, Yin T, Li YX, et al
   AAV-mediated gene transfer of human pigment epithelium-derived factor inhibits lewis lung carcinoma growth in mice.
   Oncol Rep. 2012 Jan 4. doi: 10.3892/or.2012.1621.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. JI BC , Yu CC, Yang ST, Hsia TC, et al
   Induction of DNA damage by deguelin is mediated through reducing DNA repair genes in human non-small cell lung cancer NCI-H460 cells.
   Oncol Rep. 2012 Jan 4. doi: 10.3892/or.2012.1622.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
5. WU G , Wei L, Yu A, Zhang M, et al
   Vasodilator-stimulated phosphoprotein regulates osteosarcoma cell migration.
   Oncol Rep. 2011;26:1609-15.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
6. SHIN KC , Lee KH, Lee CH, Shin IH, et al
   MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patients with lung cancer and non-malignant lung diseases.
   Oncol Rep. 2011 Nov 29. doi: 10.3892/or.2011.1566.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
7. HWANG JJ , Min SH, Sin KH, Heo YS, et al
   Altered expression of phosphatase of regenerating liver gene family in non-small cell lung cancer.
   Oncol Rep. 2011 Oct 6. doi: 10.3892/or.2011.1495.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. ZHANG Y , Wang JH, Lu Q, Wang YJ, et al
   Bag3 promotes resistance to apoptosis through Bcl-2 family members in non-small cell lung cancer.
   Oncol Rep. 2011 Oct 3. doi: 10.3892/or.2011.1486.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. MASAGO K , Fujita S, Togashi Y, Kim YH, et al
   Clinical significance of epidermal growth factor receptor mutations and insulin-like growth factor 1 and its binding protein 3 in advanced non-squamous non-small cell lung cancer.
   Oncol Rep. 2011;26:795-803.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
10. LI YJ , Zhang YX, Wang PY, Chi YL, et al
    Regression of A549 lung cancer tumors by anti-miR-150 vector.
    Oncol Rep. 2011 Sep 20. doi: 10.3892/or.2011.1466.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. GE L , Deng Z, Zhang Y, Shao W, et al
    Effect of plasmid-mediated RNA interference targeting telomerase reverse transcriptase on lung cancer cells.
    Oncol Rep. 2011 Sep 12. doi: 10.3892/or.2011.1455.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. URESHINO N , Sueoka-Aragane N, Nakamura T, Sato A, et al
    A fully integrated, automated and rapid detection system for KRAS mutations.
    Oncol Rep. 2011;26:609-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
13. CHOI YJ , Shin DY, Lee YW, Cho CK, et al
    Inhibition of cell motility and invasion by HangAmDan-B in NCI-H460 human non-small cell lung cancer cells.
    Oncol Rep. 2011 Aug 29. doi: 10.3892/or.2011.1440.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. FANG HY , Chen CY, Hung MF, Hsiao YT, et al
    Caspase-14 is an anti-apoptotic protein targeting apoptosis-inducing factor in lung adenocarcinomas.
    Oncol Rep. 2011;26:359-69.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
15. WANG J , Zhang J, Zhang L, Zhao L, et al
    Expression of P-gp, MRP, LRP, GST-pi and TopoIIalpha and intrinsic resistance in human lung cancer cell lines.
    Oncol Rep. 2011 Jul 28. doi: 10.3892/or.2011.1405.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. KOBAYASHI D , Kuribayashi K, Tanaka M, Watanabe N, et al
    Overexpression of SALL4 in lung cancer and its importance in cell proliferation.
    Oncol Rep. 2011 Jul 1. doi: 10.3892/or.2011.1374.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. CHEN L , Moore JE, Samathanam C, Shao C, et al
    CRM1-dependent p53 nuclear accumulation in lung lesions of a bitransgenic mouse lung tumor model.
    Oncol Rep. 2011;26:223-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
18. ZHAO Y , Zhu C, Li X, Zhang Z, et al
    Asterosaponin 1 induces endoplasmic reticulum stress-associated apoptosis in A549 human lung cancer cells.
    Oncol Rep. 2011 Jun 23. doi: 10.3892/or.2011.1358.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. KANAJI N , Bandoh S, Ishii T, Fujita J, et al
    Cytokeratins negatively regulate the invasive potential of lung cancer cell lines.
    Oncol Rep. 2011 Jun 23. doi: 10.3892/or.2011.1357.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. CAI YR , Zhang HQ, Qu Y, Mu J, et al
    Expression of MET and SOX2 genes in non-small cell lung carcinoma with EGFR mutation.
    Oncol Rep. 2011 Jun 15. doi: 10.3892/or.2011.1349.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. TAKEUCHI S , Zhao S, Kuge Y, Zhao Y, et al
    18F-Fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts.
    Oncol Rep. 2011 Jun 7. doi: 10.3892/or.2011.1338.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. YIN R , Zhang S, Wu Y, Fan X, et al
    microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4.
    Oncol Rep. 2011;25:1747-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. ZHANG ZQ , Zhu ZX, Bai CX, Chen ZH, et al
    Aquaporin 5 expression increases mucin production in lung adenocarcinoma.
    Oncol Rep. 2011;25:1645-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
24. LAI TC , Chow KC, Fang HY, Cho HC, et al
    Expression of xeroderma pigmentosum complementation group C protein predicts cisplatin resistance in lung adenocarcinoma patients.
    Oncol Rep. 2011;25:1243-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
25. CHOI KJ , Lee JH, Kim KS, Kang S, et al
    Identification of ELAVL4 as a modulator of radiation sensitivity in A549 non-small cell lung cancer cells.
    Oncol Rep. 2011 Apr 13. doi: 10.3892/or.2011.1260.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. KOLESAR JM , Dahlberg SE, Marsh S, McLeod HL, et al
    The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer.
    Oncol Rep. 2011 Apr 6. doi: 10.3892/or.2011.1249.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. TSENG YT , Hsia JY, Chen CY, Lin NT, et al
    Expression of the sperm fibrous sheath protein CABYR in human cancers and identification of alpha-enolase as an interacting partner of CABYR-a.
    Oncol Rep. 2011;25:1169-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
28. STATHOPOULOS GP , Armakolas A, Tranga T, Marinou H, et al
    Granulocyte colony-stimulating factor expression as a prognostic biomarker in non-small cell lung cancer.
    Oncol Rep. 2011 Mar 22. doi: 10.3892/or.2011.1226.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. KIM SH , Choi SJ, Cho YB, Kang MW, et al
    Differential gene expression during colon-to-lung metastasis.
    Oncol Rep. 2011;25:629-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. SAKUMA Y , Tsunezumi J, Nakamura Y, Yoshihara M, et al
    ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis.
    Oncol Rep. 2011;25:661-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
31. MIYAMAE Y , Shimizu K, Hirato J, Araki T, et al
    Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinoma.
    Oncol Rep. 2011 Feb 11. doi: 10.3892/or.2011.1182.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. WANG X , Chen B, Xu W, Liu S, et al
    Combined effects of klotho and soluble CD40 ligand on A549 lung cancer cells.
    Oncol Rep. 2011 Feb 9. doi: 10.3892/or.2011.1178.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
33. LUO ZG , Tang H, Li B, Zhu Z, et al
    Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
    Oncol Rep. 2011 Jan 31. doi: 10.3892/or.2011.1172.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. WANG ZM , Cui YH, Li W, Chen SY, et al
    Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
    Oncol Rep. 2011 Jan 31. doi: 10.3892/or.2011.1168.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. KURTZE I , Sonnemann J, Beck JF
    KRAS-mutated non-small cell lung cancer cells are responsive to either co-treatment with erlotinib or gefitinib and histone deacetylase inhibitors or single treatment with lapatinib.
    Oncol Rep. 2011 Jan 25. doi: 10.3892/or.2011.1160.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. SUN J , Lei Z, Liu RY, Lu Y, et al
    A haplotype of TGFBR1 is predominantly found in non-small cell lung cancer patients displaying TGFBR1 allelic-specific expression.
    Oncol Rep. 2011 Jan 10. doi: 10.3892/or.2011.1135.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. NANNINI M , Biasco G, Di Scioscio V, Di Battista M, et al
    Clinical, radiological and biological features of lung metastases in gastrointestinal stromal tumors (case reports).
    Oncol Rep. 2011;25:113-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
38. CUI F , Wang J, Chen D, Chen YJ, et al
    CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer.
    Oncol Rep. 2010 Dec 20. doi: 10.3892/or.2010.1115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. TOGASHI Y , Masago K, Fujita S, Kim YH, et al
    Association of the transforming growth factor ss1 promoter polymorphism, C-509T, with smoking status and survival in advanced non-small cell lung cancer.
    Oncol Rep. 2010 Dec 10. doi: 10.3892/or.2010.1098.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. CHEN HL , Fan LF, Gao J, Ouyang JP, et al
    Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma.
    Oncol Rep. 2010 Dec 10. doi: 10.3892/or.2010.1095.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. ZHANG T , Cui GB, Zhang J, Zhang F, et al
    Inhibition of PI3 kinases enhances the sensitivity of non-small cell lung cancer cells to ionizing radiation.
    Oncol Rep. 2010;24:1683-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. LIN YC , Lin CK, Tsai YH, Weng HH, et al
    Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells.
    Oncol Rep. 2010;24:1605-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
43. MAURO LV , Dalurzo M, Carlini MJ, Smith D, et al
    Estrogen receptor beta and epidermal growth factor receptor as early-stage prognostic biomarkers of non-small cell lung cancer.
    Oncol Rep. 2010;24:1331-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. ZHANG J , Niu XM, Liao ML, Liu Y, et al
    Discrepancy of biologic behavior influenced by bone marrow derived cells in lung cancer.
    Oncol Rep. 2010;24:1185-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. FURUGAKI K , Iwai T, Shirane M, Kondoh K, et al
    Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS.
    Oncol Rep. 2010;24:1141-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. ZHANG F , Zhang T, Qu Y, Jiang T, et al
    Replication-dependent gamma-H2AX formation is involved in docetaxel-induced apoptosis in NSCLC A549 cells.
    Oncol Rep. 2010;24:1297-305.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. ZHANG J , Du Y, Wu C, Ren X, et al
    Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186* signaling pathway.
    Oncol Rep. 2010;24:1217-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. WU YQ , Song Z, Zhou CH, Xing SH, et al
    Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo.
    Oncol Rep. 2010;24:1179-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
49. OSHITA F , Morita A, Ito H, Kameda Y, et al
    Proteomic screening of completely resected tumors in relation to survival in patients with stage I non-small cell lung cancer.
    Oncol Rep. 2010;24:637-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. MOTOMURA T , Ueda K, Ohtani S, Hansen E, et al
    Evaluation of systemic external microwave hyperthermia for treatment of pleural metastasis in orthotopic lung cancer model.
    Oncol Rep. 2010;24:591-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
51. WAN YW , Qian Y, Rathnagiriswaran S, Castranova V, et al
    A breast cancer prognostic signature predicts clinical outcomes in multiple tumor types.
    Oncol Rep. 2010;24:489-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. KOHNO H , Amatya VJ, Takeshima Y, Kushitani K, et al
    Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.
    Oncol Rep. 2010;24:423-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. LAI TC , Chow KC, Lin TY, Chiang IP, et al
    Expression of 53BP1 as a cisplatin-resistant marker in patients with lung adenocarcinomas.
    Oncol Rep. 2010;24:321-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. YANG SH , Baek HA, Lee HJ, Park HS, et al
    Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas.
    Oncol Rep. 2010;24:311-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
55. MORELLI MF , Santomaggio A, Ricevuto E, Cannita K, et al
    Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study.
    Oncol Rep. 2010;23:1635-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: